Mechanical Strain Stimulates Osteoblast Proliferation Through the Estrogen Receptor in Males as Well as Females
Open Access
- 1 November 2000
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 15 (11) , 2169-2177
- https://doi.org/10.1359/jbmr.2000.15.11.2169
Abstract
Mechanical strain, testosterone, and estrogen all stimulate proliferation of primary cultures of male rat long bone (LOB)‐derived osteoblast‐like cells as determined by [3H]thymidine incorporation. The maximum proliferative effect of a single period of mechanical strain (3400 με, 1 Hz, and 600 cycles) is additional to that of testosterone (10−8 M) or estrogen (10−8 M). The cells' proliferative response to strain is abolished both by concentrations of tamoxifen that cause proliferation (10−8 M) and by those that have no effect (10−6 M). Strain‐related proliferation also is reduced by the estrogen antagonist ICI 182,780 (10−8 M) but is unaffected by the androgen receptor antagonist hydroxyflutamide (10−7 M). Tamoxifen, ICI 182,780, and the aromatase inhibitor 4‐dihydroandrostenedione, at concentrations that have no effect on basal proliferation, significantly reduce the proliferative effect of the aromatizable androgen testosterone but not that of the nonaromatizable androgen 5α‐dihydrotestosterone. Hydroxyflutamide, at a concentration that has no effect on basal proliferation (10−7 M), eliminates the proliferative effect of 5α‐dihydro‐testosterone but had no significant effect on that caused by testosterone. Proliferation associated with strain is blocked by neutralizing antibody to insulin‐like growth factor II (IGF‐II) but not by antibody to IGF‐I. Proliferation associated with testosterone is blocked by neutralizing antibody to IGF‐I but is unaffected by antibody to IGF‐II. These data suggest that in rat osteoblast‐like cells from males, as from females, strain‐related proliferation is mediated through the estrogen receptor (ER) in a manner that does not compete with estrogen but that can be blocked by ER modulators. Proliferation associated with testosterone appears to follow its aromatization to estrogen and is mediated through the ER, whereas proliferation associated with 5α‐dihydrotestosterone is mediated by the androgen receptor. Strain‐related proliferation in males, as in females, is mediated by IGF‐II, whereas proliferation associated with estrogen and testosterone is mediated by IGF‐I.Keywords
This publication has 42 references indexed in Scilit:
- Mechanical Strain Stimulates ROS Cell Proliferation Through IGF‐II and Estrogen Through IGF‐IJournal of Bone and Mineral Research, 1999
- A PCR Analysis of ERα and ERβ mRNA Abundance in Rats and the Effect of OvariectomyJournal of Bone and Mineral Research, 1999
- The Estrogen Receptor's Involvement in Osteoblasts' Adaptive Response to Mechanical StrainJournal of Bone and Mineral Research, 1998
- Agonistic Effect of Tamoxifen Is Dependent on Cell Type, ERE-Promoter Context, and Estrogen Receptor Subtype: Functional Difference between Estrogen Receptors α and βBiochemical and Biophysical Research Communications, 1997
- Early Responses to Dynamic Strain Change and Prostaglandins in Bone-Derived Cells in CultureJournal of Bone and Mineral Research, 1997
- Osteoblast cells (MG-63 and HOS) have aromatase and 5α-reductase activitiesIUBMB Life, 1996
- Androgens Directly Stimulate Mineralization and Increase Androgen Receptors in Human Osteoblast-like Osteosarcoma CellsBiochemical and Biophysical Research Communications, 1994
- Bone and mineral metabolism in the androgen-resistant (testicular feminized) male ratJournal of Bone and Mineral Research, 1993
- Prolonged treatment with finasteride (a 5α‐reductase inhibitor) does not affect bone density and metabolismClinical Endocrinology, 1992
- Failure of isolated rat tibial periosteal cells to 5α reduce testosterone to 5α-dihydrotestosteroneJournal of Bone and Mineral Research, 1990